[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 34.204.186.91. Please contact the publisher to request reinstatement.
Article
October 1996

Effect of Topical Diphenhydramine on the Laryngeal Chemoreflex

Author Affiliations

From the University of Minnesota and Hennepin County Medical Center, Minneapolis.

Arch Otolaryngol Head Neck Surg. 1996;122(10):1112-1116. doi:10.1001/archotol.1996.01890220078013
Abstract

Objective:  To study diphenhydramine nebulization as a clinically applicable method for blunting laryngeal chemoreflex (LCR)-associated apnea.

Intervention:  Fourteen piglets aged 15 to 18 days were studied. In 7 piglets, diphenhydramine hydrochloride (5.0 mg/kg) was nebulized onto the laryngeal mucosa after a baseline response was obtained.

Results:  After a 10-minute waiting period, the mean±SD LCR-induced apnea duration decreased from 29± 13 seconds in the control animals to 15±5 seconds in the treated group (P=.02, 1-factor analysis of variance). After 1 hour, no treatment effect was seen.

Conclusions:  Nebulization of diphenhydramine can effectively reduce LCR-induced apnea for a short time. Nebulization of longer-acting agents may provide an effective prophylaxis of LCR-induced apnea.Arch Otolaryngol Head Neck Surg. 1996;122:1112-1116

×